American International Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,804
| Closed | -$958K | – | 3179 |
|
|
2020
Q3 | $958K | Sell |
27,804
-633
| -2% | -$21.8K | ﹤0.01% | 1267 |
|
|
2020
Q2 | $475K | Buy |
28,437
+1,796
| +7% | +$30K | ﹤0.01% | 1621 |
|
|
2020
Q1 | $384K | Sell |
26,641
-1,538
| -5% | -$22.2K | ﹤0.01% | 1556 |
|
|
2019
Q4 | $943K | Buy |
28,179
+124
| +0.4% | +$4.15K | ﹤0.01% | 1364 |
|
|
2019
Q3 | $587K | Sell |
28,055
-194
| -0.7% | -$4.06K | ﹤0.01% | 1573 |
|
|
2019
Q2 | $588K | Buy |
28,249
+334
| +1% | +$6.95K | ﹤0.01% | 1615 |
|
|
2019
Q1 | $624K | Sell |
27,915
-905
| -3% | -$20.2K | ﹤0.01% | 1578 |
|
|
2018
Q4 | $689K | Buy |
28,820
+92
| +0.3% | +$2.2K | ﹤0.01% | 1487 |
|
|
2018
Q3 | $784K | Buy |
28,728
+517
| +2% | +$14.1K | ﹤0.01% | 1601 |
|
|
2018
Q2 | $759K | Buy |
28,211
+5,485
| +24% | +$148K | ﹤0.01% | 1565 |
|
|
2018
Q1 | $723K | Sell |
22,726
-978
| -4% | -$31.1K | ﹤0.01% | 1469 |
|
|
2017
Q4 | $896K | Buy |
23,704
+113
| +0.5% | +$4.27K | ﹤0.01% | 1430 |
|
|
2017
Q3 | $585K | Buy |
23,591
+1,764
| +8% | +$43.7K | ﹤0.01% | 1661 |
|
|
2017
Q2 | $449K | Buy |
21,827
+5,643
| +35% | +$116K | ﹤0.01% | 1779 |
|
|
2017
Q1 | $352K | Buy |
16,184
+1,070
| +7% | +$23.3K | ﹤0.01% | 1847 |
|
|
2016
Q4 | $309K | Sell |
15,114
-40
| -0.3% | -$818 | ﹤0.01% | 1927 |
|
|
2016
Q3 | $227K | Buy |
15,154
+23
| +0.2% | +$345 | ﹤0.01% | 2078 |
|
|
2016
Q2 | $164K | Buy |
15,131
+8,711
| +136% | +$94.3K | ﹤0.01% | 2275 |
|
|
2016
Q1 | $87K | Buy |
+6,420
| New | +$87K | ﹤0.01% | 3533 |
|